{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:09:41Z","timestamp":1791587381427,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.medcli.2022.10.007","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T12:35:17Z","timestamp":1671107717000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["S\u00edndrome de Sj\u00f6gren"],"prefix":"10.1016","volume":"160","author":[{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Retamozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2022.10.007_bib0305","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keh714","article-title":"Primary Sj\u00f6gren's syndrome: Current and emergent aetiopathogenic concepts","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0310","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.medcli.2022.10.007_bib0315","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12016-009-8152-z","article-title":"Sj\u00f6gren syndrome or Sj\u00f6gren disease? The histological and immunological bias caused by the 2002 criteria","volume":"38","author":"Ramos-Casals","year":"2010","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0320","doi-asserted-by":"crossref","first-page":"102448","DOI":"10.1016\/j.autrev.2019.102448","article-title":"The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project)","volume":"19","author":"Sis\u00f3-Almirall","year":"2020","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.medcli.2022.10.007_bib0325","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sjogren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2022.10.007_bib0330","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40266-021-00838-6","article-title":"Therapeutic recommendations for the management of older adult patients with Sj\u00f6gren's syndrome","volume":"38","author":"Retamozo","year":"2021","journal-title":"Drugs Aging."},{"key":"10.1016\/j.medcli.2022.10.007_bib0335","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/rheumatology\/keab032","article-title":"Childhood-onset of primary Sj\u00f6gren's syndrome: Phenotypic characterization at diagnosis of 158 children","volume":"60","author":"Ramos-Casals","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.55563\/clinexprheumatol\/egnd1i","article-title":"Influence of the age at diagnosis in the disease expression of primary Sj\u00f6gren syndrome. Analysis of 12,753 patients from the Sj\u00f6gren Big Data Consortium","volume":"39","author":"Retamozo","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0345","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren's syndrome at diagnosis in 8310 patients: A cross-sectional study from the Big Data Sj\u00f6gren Project Consortium","volume":"76","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0350","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/rheumatology\/kez578","article-title":"Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sj\u00f6gren's syndrome","volume":"59","author":"Brito-Zer\u00f3n","year":"2020","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0025-7753(01)71958-6","article-title":"[Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases] Spanish","volume":"116","author":"Ramos-Casals","year":"2001","journal-title":"Med Clin (Barc)."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0360","first-page":"114","article-title":"Sicca\/Sjogren's syndrome triggered by PD-1\/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)","volume":"37","author":"Ramos-Casals","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0365","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/3bvq48","article-title":"Practical diagnostic tips for the Sj\u00f6gren clinic: Pearls, myths and mistakes","author":"Brito-Zer\u00f3n","year":"2022","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0370","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sj\u00f6gren's syndrome and co-aggregation of autoimmune diseases in affected families: A nationwide population study","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0375","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sj\u00f6gren's syndrome: Autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0380","first-page":"3","article-title":"Sjogren's syndrome: Mechanisms of pathogenesis involve interaction of immune and neurosecretory systems","volume":"116","author":"Fox","year":"2002","journal-title":"Scand J Rheumatol Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0385","first-page":"198","article-title":"Phenotyping Sj\u00f6gren's syndrome: Towards a personalised management of the disease","volume":"36","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120398678920019","article-title":"Young onset of primary Sj\u00f6gren's syndrome: Clinical and immunological characteristics","volume":"7","author":"Ramos-Casals","year":"1998","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2022.10.007_bib0395","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/rheumatology\/keq009","article-title":"Primary Sjogren's syndrome: Too dry and too tired","volume":"49","author":"Ng","year":"2010","journal-title":"Rheumatology (Oxford)."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0400","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: Analysis of 10,500 patients (Sjogren Big Data Project)","volume":"36","author":"Brito-Zeron","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0405","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjogren's syndrome: Results of a large multicentre study","volume":"44","author":"Quartuccio","year":"2015","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0415","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","article-title":"Cutaneous vasculitis in primary Sj\u00f6gren syndrome: Classification and clinical significance of 52 patients","volume":"83","author":"Ramos-Casals","year":"2004","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0420","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0961203313515764","article-title":"Annular erythema in primary Sjogren's syndrome: Description of 43 non-Asian cases","volume":"23","author":"Brito-Zeron","year":"2014","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2022.10.007_bib0425","first-page":"647","article-title":"Bronchiectasis in primary Sj\u00f6gren's syndrome: Prevalence and clinical significance","volume":"28","author":"Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0430","first-page":"103","article-title":"Classification and characterisation of peripheral neuropathies in 102 patients with primary Sj\u00f6gren's syndrome","volume":"31","author":"Brito-Zer\u00f3n","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/hcr218","article-title":"White matter abnormalities in primary Sj\u00f6gren syndrome","volume":"105","author":"Akasbi","year":"2012","journal-title":"QJM."},{"key":"10.1016\/j.medcli.2022.10.007_bib0440","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/rheumatology\/keaa257","article-title":"Refining myositis associated with primary Sj\u00f6gren's syndrome: Data from the prospective cohort ASSESS","volume":"60","author":"Felten","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0445","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","article-title":"Primary Sj\u00f6gren syndrome: Hematologic patterns of disease expression","volume":"81","author":"Ramos-Casals","year":"2002","journal-title":"Medicine (Baltimore)."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0450","first-page":"97","article-title":"Systemic manifestations of primary Sj\u00f6gren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients","volume":"37","author":"Retamozo","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0455","first-page":"95","article-title":"Autoimmune congenital heart block and primary Sj\u00f6gren's syndrome: Characterisation and outcomes of 49 cases","volume":"38","author":"Brito-Zer\u00f3n","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0460","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: Clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.medcli.2022.10.007_bib0465","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","article-title":"The overlap of Sj\u00f6gren's syndrome with other systemic autoimmune diseases","volume":"36","author":"Ramos-Casals","year":"2007","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.medcli.2022.10.007_bib0470","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3899\/jrheum.090835","article-title":"Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren's syndrome","volume":"37","author":"Ramos-Casals","year":"2010","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0475","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/joim.12992","article-title":"Weight of salivary gland ultrasonography compared to other items of the 2016 ACR\/EULAR classification criteria for primary Sj\u00f6gren's syndrome","volume":"287","author":"Jousse-Joulin","year":"2020","journal-title":"J Intern Med."},{"key":"10.1016\/j.medcli.2022.10.007_bib0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0485","doi-asserted-by":"crossref","first-page":"197","DOI":"10.55563\/clinexprheumatol\/pal3z7","article-title":"Practical guidelines for the early diagnosis of Sj\u00f6gren's syndrome in primary healthcare","volume":"39","author":"Sis\u00f3-Almirall","year":"2021","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0490","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren's syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sj\u00f6grens syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0500","first-page":"85","article-title":"Systemic phenotype related to primary Sj\u00f6gren's syndrome in 279 patients carrying isolated anti-La\/SSB antibodies","volume":"38","author":"Acar-Denizli","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0049-0172(98)80037-1","article-title":"Cryoglobulinemia in primary Sj\u00f6gren's syndrome: Prevalence and clinical characteristics in a series of 115 patients","volume":"28","author":"Ramos-Casals","year":"1998","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.medcli.2022.10.007_bib0510","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: Analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0515","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2012.01.010","article-title":"Monoclonal gammopathy related to Sj\u00f6gren syndrome: A key marker of disease prognosis and outcomes","volume":"39","author":"Brito-Zer\u00f3n","year":"2012","journal-title":"J Autoimmun."},{"key":"10.1016\/j.medcli.2022.10.007_bib0525","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sj\u00f6gren's syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0535","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-007-8006-5","article-title":"Lessons from diseases mimicking Sj\u00f6gren's syndrome","volume":"32","author":"Ramos-Casals","year":"2007","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0540","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","article-title":"Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sj\u00f6gren's syndrome: A randomised, double-blind, placebo-controlled, phase 2b dose-finding trial","volume":"399","author":"Bowman","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2022.10.007_bib0545","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1080\/14656566.2021.1951224","article-title":"An update of targeted therapeutic options for primary Sj\u00f6gren syndrome: Current status and future development","volume":"22","author":"Retamozo","year":"2021","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.medcli.2022.10.007_bib0550","doi-asserted-by":"crossref","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): A user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open."},{"key":"10.1016\/j.medcli.2022.10.007_bib0555","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0961203310367504","article-title":"Cardiovascular risk factors in primary Sjogren's syndrome: A case-control study in 624 patients","volume":"19","author":"Perez-de-Lis","year":"2010","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2022.10.007_bib0560","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0565","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2007.074203","article-title":"Exocrine function in primary Sj\u00f6gren syndrome: Natural course and prognostic factors","volume":"67","author":"Haldorsen","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0570","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1157\/13115353","article-title":"Evoluci\u00f3n y pron\u00f3stico del paciente con s\u00edndrome de Sj\u00f6gren primario","volume":"130","author":"Brito-Zer\u00f3n","year":"2008","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1873-3468.12933","article-title":"How stress contributes to autoimmunity-lessons from Sjogren's syndrome","volume":"592","author":"Skopouli","year":"2018","journal-title":"FEBS Lett."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2022.10.007_bib0580","first-page":"121","article-title":"Severe, life-threatening phenotype of primary Sj\u00f6gren's syndrome: Clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)","volume":"36","author":"Flores-Ch\u00e1vez","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.medcli.2022.10.007_bib0585","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2022.10.007_bib0590","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sj\u00f6gren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2022.10.007_bib0595","first-page":"keac205","article-title":"Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies","author":"Hern\u00e1ndez-Molina","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2022.10.007_bib0600","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322005590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T05:19:00Z","timestamp":1676092740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775322005590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0025775322005590"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2022.10.007","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de Sj\u00f6gren","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2022.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}